Cingulate Inc. (NASDAQ:CINGW) Short Interest Down 66.1% in May

Cingulate Inc. (NASDAQ:CINGW) saw a significant decline in short interest during the month of May. As of May 15th, there was short interest totaling 3,796 shares, a decline of 66.1% from the April 30th total of 11,190 shares. Based on an average daily trading volume, of 16,655 shares, the days-to-cover ratio is presently 0.2 days.

Cingulate Stock Up 1.7%

Shares of CINGW stock traded up $0.00 during trading hours on Monday, reaching $0.04. 15,519 shares of the company’s stock were exchanged, compared to its average volume of 42,567. Cingulate has a fifty-two week low of $0.02 and a fifty-two week high of $0.18. The business has a fifty day moving average price of $0.03 and a 200-day moving average price of $0.05.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.